Insider selling
Traded Dec 13, 2024 · filed 5 days laterNot reported under a pre-arranged trading plan
An Olema Pharmaceuticals director sold $4.73M of Olema Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 4, 2024 · Filed Nov 26, 2024
An Olema Pharmaceuticals director sold $7.05M of Olema Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$7,053,750
Shares × reported transaction price
27 days after results of May 8, 2024, 63 days before results of Aug 6, 2024
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.3% | +1.5% | −1.8% |
| 30 days | −39.2% | −0.6% | −38.6% |
| 90 days | −54.0% | −0.8% | −53.2% |
| 180 days | −49.1% | −1.3% | −47.8% |
| 365 days | +179.8% | +14.1% | +165.7% |
Past results only. Not a forecast.
Insider selling
Traded Dec 13, 2024 · filed 5 days laterNot reported under a pre-arranged trading plan
An Olema Pharmaceuticals director sold $4.73M of Olema Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Dec 17, 2024 · filed 1 day laterNot reported under a pre-arranged trading plan
An Olema Pharmaceuticals director sold $4.73M of Olema Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider buying
Traded Dec 13, 2024 · filed 5 days later
An Olema Pharmaceuticals director paid $4.73M out of pocket for Olema Pharmaceuticals shares. 1 other person at Olema Pharmaceuticals bought some too, in the same month.